title: Rapid analysis of pharmacology for infectious diseases.
abstract: Pandemic, epidemic and endemic infectious diseases are united by a common problem: how do we rapidly and cost-effectively identify potential pharmacological interventions to treat infections? Given the large number of emerging and neglected infectious diseases and the fact that they disproportionately afflict the poorest members of the global society, new ways of thinking are required to developed high productivity discovery systems that can be applied to a larger number of pathogens. The growing availability of parasite genome data provides the basis for developing methods to prioritize, a priori, the potential drug target and pharmacological landscape of an infectious disease. Thus the overall objective of infectious disease informatics is to enable the rapid generation of plausible, novel medical hypotheses of testable pharmacological experiments, by uncovering undiscovered relationships in the wealth of biomedical literature and databases that were collected for other purposes. In particular our goal is to identify potential drug targets present in a pathogen genome and prioritize which pharmacological experiments are most likely to discover drug-like lead compounds rapidly against a pathogen (i.e. which specific compounds and drug targets should be screened, in which assays and where they can be sourced). An integral part of the challenge is the development and integration of methods to predict druggability, essentiality, synthetic lethality and polypharmacology in pathogen genomes, while simultaneously integrating the inevitable issues of chemical tractability and the potential for acquired drug resistance from the start.
authors.affiliation: Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, UK. a.hopkins@dundee.ac.uk
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Hopkins
authors.forename: G Richard
authors.initials: GR
authors.lastname: Bickerton
authors.forename: Ian M
authors.initials: IM
authors.lastname: Carruthers
authors.forename: Stephen K
authors.initials: SK
authors.lastname: Boyer
authors.forename: Harvey
authors.initials: H
authors.lastname: Rubin
authors.forename: John P
authors.initials: JP
authors.lastname: Overington
mesh_terms: D000818:Animals; D003141:Communicable Diseases / Q000188:drug therapy* / Q000453:epidemiology; D015195:Drug Design; D058872:Epidemics; D016678:Genome; D023281:Genomics / Q000639:trends; D006801:Humans